Cargando…

Long-Term Survival and Risk Factors in Patients with Hepatitis B-Related Hepatocellular Carcinoma: A Real-World Study

A retrospective cohort study was conducted to collect 465 patients with hepatitis B-related hepatocellular carcinoma who had undergone radical hepatectomy from January 1, 2012, to August 31, 2018, at the First Affiliated Hospital of the University of Science and Technology of China. The clinical, pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yu, Gu, Ling-Ling, Zhang, Fa-Biao, Zheng, Guo-Qun, Chen, Ting, Jia, Wei-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427325/ https://www.ncbi.nlm.nih.gov/pubmed/36051249 http://dx.doi.org/10.1155/2022/7750140

Ejemplares similares

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study
por: Luo, Yang, et al.
Publicado: (2020)

Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
por: Lee, I-Cheng, et al.
Publicado: (2015)

Long‐term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinoma
por: Tong, Myron J., et al.
Publicado: (2017)

Long-term survival after resection of hepatocellular carcinoma
por: Kim, Ki Hoon, et al.
Publicado: (2012)

Identification of predictors of long‐term survival and prognostic outcomes in thymic squamous cell carcinoma: A real‐world study
por: Zhou, Meng‐Xin, et al.
Publicado: (2023)

Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma
por: Liu, Wei, et al.
Publicado: (2016)

Long-Term Survival in a Patient With Ruptured Hepatocellular Carcinoma
por: Kim, Joon Sung, et al.
Publicado: (2009)

Real-World Use of Immunotherapy for Hepatocellular Carcinoma
por: Sara, Amir, et al.
Publicado: (2023)

Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience
por: Yu, Jie, et al.
Publicado: (2022)

Clinical conditions and treatment requirements for long‐term survival among hepatitis B‐related hepatocellular carcinoma initially treated with chemoembolization
por: Chen, Zhen‐Xin, et al.
Publicado: (2019)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Long-Term Survival Analysis of Transarterial Chemoembolization Plus Radiotherapy vs. Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion
por: Su, Ting-Shi, et al.
Publicado: (2020)

Survival after Locoregional Treatments for Hepatocellular Carcinoma: A Cohort Study in Real-World Patients
por: Signoriello, Simona, et al.
Publicado: (2012)

Effects of Early TACE Refractoriness on Survival in Patients with Hepatocellular Carcinoma: A Real-World Study
por: Yang, Chao, et al.
Publicado: (2022)

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2013)

Long-term survival outcome of laparoscopic liver resection for hepatocellular carcinoma
por: Lam, Shi, et al.
Publicado: (2021)

Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation
por: Zhang, Qing, et al.
Publicado: (2016)

Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening
por: Izzo, Francesco, et al.
Publicado: (2022)

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
por: Yu, Ming-Whei, et al.
Publicado: (2022)

Hepatic Resection Is Associated With Improved Long-Term Survival Compared to Radio-Frequency Ablation in Patients With Multifocal Hepatocellular Carcinoma
por: Yue, Yang-yang, et al.
Publicado: (2020)

Long-term survival of patients with hepatocellular carcinoma with hepatic, pulmonary, peritoneal and rare colon metastasis: A case report
por: Gong, Yong-Qiang, et al.
Publicado: (2023)

Correction: Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma
por: Gu, Xuefeng, et al.
Publicado: (2020)

Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
por: Lu, Qiang, et al.
Publicado: (2020)

Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model
por: Hsu, Chia-Yang, et al.
Publicado: (2014)

Diabetes mellitus affects long-term survival in hepatitis B virus-related hepatocellular carcinoma patients: A propensity score-matched analysis
por: Zhang, Haili, et al.
Publicado: (2021)

Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
por: Kong, Jie-Yu, et al.
Publicado: (2018)

Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma
por: Zeng, Xianghua, et al.
Publicado: (2023)

Serum Prealbumin is Negatively Associated with Survival in Hepatocellular Carcinoma Patients after Hepatic Resection
por: Liao, Ying-Yang, et al.
Publicado: (2019)

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
por: Wu, Xiaoning, et al.
Publicado: (2023)

Short‐term efficacy and long‐term survival of nasopharyngeal carcinoma patients with radiographically visible residual disease following observation or additional intervention: A real‐world study in China
por: Huang, Ying‐Ying, et al.
Publicado: (2022)

Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients
por: Chen, Jinzhang, et al.
Publicado: (2020)

A novel DNA methylation‐driver gene signature for long‐term survival prediction of hepatitis‐positive hepatocellular carcinoma patients
por: Fu, Jie, et al.
Publicado: (2022)

Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
por: Wong, Linda L., et al.
Publicado: (2017)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
por: Zheng, Zhuangzhuang, et al.
Publicado: (2022)

Long-Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real-World Setting: A Retrospective Study
por: Hou, Zhi-Jun, et al.
Publicado: (2020)

Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
por: Chen, Bowen, et al.
Publicado: (2022)

Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
por: Kim, Nalee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kugm1op476njckmarbhreo1svn